Home / Recalls
Consumer Product Recalls
127,244 recalls from the U.S. Consumer Product Safety Commission, newest first.
November 5, 2025DrugsFDA
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride Tablets, USP, 100 mg, 100 count bottle (NDC 23155-582-01), Rx only, Manufactured by: USV Priva
Hazard: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
November 5, 2025DrugsFDA
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride Tablets, USP, 75 mg, 100 count bottle (NDC 23155-581-01), Rx only, Manufactured by: USV Privat
Hazard: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
November 5, 2025DrugsFDA
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride Tablets, USP, 50 mg, 100 count bottle (NDC 23155-580-01), Rx only, Manufactured by: USV Privat
Hazard: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
November 5, 2025DrugsFDA
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride Tablets, USP, 25 mg, 100 count bottle (NDC 23155-579-01), Rx only, Manufactured by: USV Privat
Hazard: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
November 5, 2025DrugsFDA
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride Tablets, USP, 10 mg, 100 - count bottle (NDC 23155-578-01), Rx only, Manufactured by: USV Priv
Hazard: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
November 5, 2025DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Prazosin Hydrochloride, Capsules, USP, 5 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 194
Hazard: CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.
November 5, 2025DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 194
Hazard: CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.
November 5, 2025DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Prazosin Hydrochloride, Capsules, USP, 1 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 194
Hazard: CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.
November 5, 2025DrugsFDA
Amerisource Health Services LLC recalls Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packagin
Hazard: Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
November 5, 2025DrugsFDA
Amerisource Health Services LLC recalls Prazosin Hydrochloride, Capsules, USP, 2 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packa
Hazard: Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
November 5, 2025DrugsFDA
Amerisource Health Services LLC recalls Prazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packa
Hazard: Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
November 5, 2025DrugsFDA
Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules, USP, 60 mg, a.) 90-count bottle (NDC: 51991-748-90), b.)1000-count bottle (NDC 519
Hazard: CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment limit of 12.5ppm.
November 5, 2025DrugsFDA
Samsung Bioepis Co., Ltd. recalls HADLIMA (adalimumab-bwwd) injection, 40mg/0.8 mL, 2 Single-dose Prefilled Syringes per carton, Rx only, Manufactured for
Hazard: Lack of Assurance of Sterility.
November 5, 2025VehiclesNHTSA
Wabash 2025–2026 Structure recall
Hazard: The incorrect guard may not sufficiently protect a following vehicle during a rear end crash, increasing the risk of injury.
November 5, 2025VehiclesNHTSA
Endera 2024–2026 Equipment Adaptive/Mobility recall
Hazard: An unlocked wheelchair can move during transit or during a crash, increasing the risk of injury.
November 5, 2025Vehicle EquipmentNHTSA
Bendix Service Brakes, Air recall
Hazard: Safety systems that depend on the ECU (Automatic Traction Control, ABS, Electronic Stability Control, Active Cruise Control, and Collison Mitigation System) may have diminished or lost functionality, increasing the risk of a crash.
November 5, 2025Vehicle EquipmentNHTSA
Tuftrac Suspension recall
Hazard: A loss of vehicle control increases the risk of a crash.
November 4, 2025VehiclesNHTSA
Freightliner, Western Star 2020–2026 Suspension recall
Hazard: A loss of vehicle control increases the risk of a crash.
November 4, 2025VehiclesNHTSA
Spartan Fire 2024–2025 Latches/Locks/Linkages recall
Hazard: A door that cannot be opened may trap occupants inside the vehicle, increasing the risk of injury.
November 3, 2025VehiclesNHTSA
Volvo 2026 Exterior Lighting recall
Hazard: Marker lights that fail to illuminate can reduce visibility to other drivers, increasing the risk of a crash.
November 3, 2025VehiclesNHTSA
Mack 2024–2025 Exterior Lighting recall
Hazard: Loss of headlight illumination can reduce visibility, increasing the risk of a crash.
November 3, 2025VehiclesNHTSA
Mcneilus 2021–2025 Exterior Lighting recall
Hazard: Missing reflectors and rear clearance lights can reduce the vehicle's visibility to other drivers, increasing the risk of a crash.
November 3, 2025VehiclesNHTSA
Mcneilus 2024–2025 Exterior Lighting recall
Hazard: Missing reflectors can reduce the vehicle's visibility to other drivers, increasing the risk of a crash.
November 3, 2025VehiclesNHTSA
Volvo 2019–2026 Seat Belts recall
Hazard: A seat belt anchor that fails will not properly restrain an occupant in a crash, increasing the risk of injury.
October 31, 2025VehiclesNHTSA
Micro Bird 2024–2026 Equipment Adaptive/Mobility recall
Hazard: An unlocked wheelchair can move during transit or during a crash, increasing the risk of injury.
October 31, 2025VehiclesNHTSA
Micro Bird 2023–2026 Equipment Adaptive/Mobility recall
Hazard: An unlocked wheelchair can move during transit or during a crash, increasing the risk of injury.
October 31, 2025VehiclesNHTSA
Safari Condo 2019–2020 Equipment recall
Hazard: A gas leak in the presence of an ignition source can increase the risk of a fire.
October 31, 2025VehiclesNHTSA
Heil 2023–2025 Fuel System, Other recall
Hazard: A natural gas leak in the presence of an ignition source increases the risk of a fire.
October 31, 2025VehiclesNHTSA
BMW 2000–2001 Air Bags recall
Hazard: An inflator explosion may result in sharp metal fragments striking the driver or other occupants, resulting in serious injury or death.
October 30, 2025FurnitureCPSC
WLIVE Fabric Drawer Dressers Recall Expanded to Include 16-Drawer Dressers Due to Risk of Serious Injury or Death from Tip-Over and Entrapment; Violates Mandatory Standard for Clothing Storage Units; Sold on Amazon by WLIVE
Hazard: The recalled dressers are unstable if they are not anchored to the wall, posing serious tip-over and entrapment hazards that can result in injuries or death to children. The dressers violate the mandatory standard as required by the STURDY Act.